A traditional, protein-based COVID-19 vaccine developed by Novavax and targeting the JN.1 variant will become available next Wednesday to those eligible for free vaccination, the Centers for Disease Control (CDC) said Tuesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares close up 1.51%
09/04/2026 01:52 PM - Society
Sika deer safe after escaping to take nighttime stroll in Kaohsiung
09/04/2026 12:52 PM - Society
Court orders driver who rammed taxi into prosecutors office detained
09/04/2026 12:08 PM - Society
Heavy rain warning issued for northern, northeastern Taiwan
09/04/2026 11:11 AM - Society
Taiwan headline news
09/04/2026 10:16 AM